Jacob Gottlieb is an entrepreneur who has ventured in Altium capital investments, which is based in New York City. The primary objective of this healthcare oriented firm is to look for opportunities relating to the healthcare industry. Lately, The Altium Capital has invested in Oramed Pharmaceuticals, Amarin Corporation (AMRN) as well as Oragenics.
Oramed has come up with a significant alternative oral treatment for diabetes patients. At first, it received a stake of about 5.6 % from the Altium. Oramed has been able to test and release orally ingestible insulin capsule (ORMD-0801) and also oral Glucagon-like peptide -1 (GLP-1) analog (exenatide) capsule (ORMD-0901). Amarin is found in Duplin, Ireland and has its offices in Bedminster in New Jersey. The Company develops drugs to improve cardiovascular health. It combines lipid science and the likely benefits of saturated fatty acids.
Oragenics was founded in 1996. It focuses on the Replacement Therapy. The company provides novel antibiotics against infectious diseases. It has joined hands with Intrexon Corporation and has come up with new technologies that enable quick development of essential antibiotics. Sellas Life Sciences focusses on the treatment of arrays of many cancer indications. It has developed a technique which can transform medical care for patients with cancer. Sellas Life Sciences is located at New York City.
Before the development of the Altium, Gottlieb established the Visium Asset Management in 2005. He employed more than 200 people, and the company was making a profit of about $8 billion. Visium Asset Management Company is found in New York City, London, and San Francisco. Gottlieb was also a founding member at Balyasny Asset Management, L.P. (BAM). He was a manager of the Investment portfolio at Merlin in New York City. Furthermore, Gottlieb held a position as an analyst at Sanford C. Bernstein & C., LLC.
The focus on technological improvements has greatly impacted on the performance and growth of GreenSky Credit Firm. This is an organization based in New York that aids other credit firms in their lending operations by offering them financial and technological support. Recently, GreenSky has launched an online platform that has turned tables for both the borrowers and the financial institutions. This platform has ensured that the process of loan application has is smooth and also efficient. The efficiency features through the time used to complete theapplication process. Customers can fill in the application details and get their loans approved within seconds.
Paperwork and movements of the loan applicantshave also been alleviated by the platform, by ensuring that the application can be made through the computers or even at the comfort of the applicants’ smartphones. All the customers are required to do is to get into the GreenSky Credit website and fill in their personal and loan credentials. They are then required to submit the applications, which are then remitted to the credit facility from which the customer is borrowing. Then the financial institution reviews the details and either approves or declines the application. Once the application has been approved, a process that takes few seconds, the funds are processed by GreenSky Creditand remitted to the borrower’s account within the following forty-eight hours.
The main reason behind the success of GreenSky Credit is the leadership pillar that the company possesses. Led by the organization’s President, David Zalik, the employees of the company have been trained to establish and nurture professional business relationships with theinterested financial organizations. As a result, GreenSky Credit has entered into partnerships with many financial institutions in the country, which it has leveraged to increase its clientele base. GreenSky Credit has used this approach for years since it was established and it has proved to be quite fruitful in a myriad of ways. One of the ways that the company has realized the fruition of the approach is by the rapid growth of its valuation figure. At the end of last year, Zalik David, the CEO and President of the firm was happy to announce the company’s worth of $3.5 billion after valuation.
Stream Energy, a direct sale energy company based in Dallas, Texas, was recently featured in an article on Patch for solidifying their commitment to compassion and community. Where most lucrative businesses focus solely on profit margins and bottom lines, Stream Energy has chosen to shift its priorities towards customers in crisis after the surrounding area was affected by hurricane damage.
When hurricane Harvey tore through the Texas coast, the area was devastated. The rain and wind were relentless as those near and far stood powerless to help. It was the kind of severe natural disaster that leaves many people displaced and their lives forever altered. Loved ones and pets were lost as public and private property damages soared. No one could stop it from happening, but when the rains eased and the damage was surveyed there was a company ready to act. Stream Energy did not hesitate to provide their assistance through their charitable foundation known as Steam Cares.
Community outreach and support have been and integral part of the Stream Energy business model for over a decade. This commitment is the entire reason There is a charitable arm of such a profitable company. Their financial successes have allowed them to partner with and give back to the community that supports them. Their partnerships with organizations such as Habitat For Humanity and the Red Cross have helped make them a particularly effective partner in combating the issue of homelessness in the Dallas area.
To deliver aid and supplies to those in need after the hurricane, Stream Cares teamed up with the Hope Supply Co. It was through this partnership that food and supplies reached the families in need of it. This act of kindness and generous contributions like it make the highly profitable energy company is helping give Texans the hand they need while they recover from the aftermath of Harvey and beyond.
Whistleblowing has often been considered ethical under many circumstances. For instance, if the company is going to harm the public, a whistleblower comes in handy to educate the people and issue negated reports with the intention of arresting the management. Also, when the immediate supervisor of the employee does not come forward with the report, it becomes the responsibility of the whistleblower to report the issues. That brings you to Sahm Adrangi.
Sahm Adrangi is the head cheerleaderof Kerrisdale Capital Management. He established the company in 2009. But before that, he was employed as an analyst by the Deutsche Bank. He then joined Chanin Capital Partners where he served as an analyst in bankruptcy. He later joined Longacre Fund Management as an analyst as well. Here, he oversaw distressed debt fund. At the same time, he became prominent for publishing research on finance. Today, he is a prominent whistleblower who exposes fraudulent companies. The companies he first exposed include China Marine Food Group, China-Biotics, andLihua Internationalamong others. Additional Chinese targets have been charged by the SEC.
Duties and Roles
Since the establishment of Kerrisdale Capital Management, Adrangi has worked hard to develop the firm’s portfolio. What he started with about $1 million has now become worth $150 million. In his tenure, the company has conducted various researches on companies as well as industries. Currently, Sahm Adrangi has shifted his focus towards biotechnology where the company capitalizes on emerging companies likePulse Biosciences, and Zafgen, among others. Other than that, Kerrisdale Capital Management also focuses on exposing companies that offer false data on stocks, and telecommunication.
Recently, Sahm Adrangi issued a report on St. Joe Company. According to the $1 billion firm that deals with real estate, there are hopes to change desolate land adjacent to the Panama City into a major attraction site for retirees. However, according to Adrangi, this is highly unlikely. He reiterates that the firm’s financial position cannot sustain the project. He also adds that Joe will have to assume more than 2,000 home sites. While that is what Joe claims to have achieved, Sahm Adrangi and his team are sure that there is no progress. In fact, the company has not achieved half of what it claims.
Eric Lefkosky is the co-founder and CEO of Tempus, which is a technology company. The company uses data collected from patients and doctors in order to determine a more personalized treatment for patients. The goal is that all the data gathered, in turn, will improve the efficiency of the treatment given to the patients. Which, in turn, will eventually be able to wipe out diseases like cancer.
The company received $80 million in funding from investors. These investors included New Enterprise Associates, Revolution Growth, Kinship Trust Co, and T. Rowe Price Associates. Tempus has received $210 million in finding since 2015 when the company was founded. With the latest funding, Tempus is valued at around $1.1 billion. This valuation boosts the company to “unicorn” status. Not too many Chicago based start-ups have the privilege of sharing this status with Tempus. To know more click here.
Tempus has roughly 400 employees, but according to Eric Lefkofsky, the company is quickly adding more employees each month. Lefkofsky credits the reason behind his company being on the fast track to the fact everyone in the medical industry from doctors, drug companies, and others in the healthcare system all want to be able to utilize big data to provide the best treatment for their patients.
Tempus is not Lefkofsy’s only involvement when it comes to improving the quality of life. He has also created a private foundation, with his wife, called the Lefkofsky Family Foundation. The foundation has a mission of advancing initiatives that could have a positive impact on communities and the lives of people who are served by the foundation. They do this by placing an importance on education, making sure that women and girls are given the rights that they deserve, expand medical research, and also advocate for cultural initiatives.